Announcements Trials
Browse Landscape

Phase

Phase 3 14Phase 2 7Phase NA 5Phase 1/2 5Phase 1 4Phase 4 3Phase EARLY_PHASE1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Lymphoma 39Lymphoma, Non-Hodgkin 37Lymphoma, B-Cell 36Precursor Cell Lymphoblastic Leukemia-Lymphoma 34Burkitt Lymphoma 27Lymphoma, Large B-Cell, Diffuse 21Lymphoma, Follicular 20Leukemia, Lymphocytic, Chronic, B-Cell 16Lymphoma, Mantle-Cell 15Leukemia 13Recurrence 12Multiple Myeloma 12Hodgkin Disease 12Leukemia, Myeloid, Acute 10Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma, T-Cell 9Myelodysplastic Syndromes 8Lymphoma, T-Cell, Peripheral 8Mycosis Fungoides 6Lymphoma, T-Cell, Cutaneous 6Leukemia, B-Cell 6Neoplasms, Plasma Cell 5Neoplasms 5Lymphoma, Extranodal NK-T-Cell 5Lymphoma, B-Cell, Marginal Zone 5Waldenstrom Macroglobulinemia 4Sarcoma 4Primary Myelofibrosis 4Melanoma 4Lymphoma, Large-Cell, Anaplastic 4

Interventions

siltuximab 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Anemia × Lymphoid × Clear all
NCT02805868 2016-10-24

Siltuximab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis

Northwestern University

Phase EARLY_PHASE1 Withdrawn
Classical hematologyLymphoidMyeloid

Anemia, Lymphoma, Follicular, Polycythemia Vera, Thrombocytopenia, Thrombocytosis, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡